CoChat
Sign Up
Cited by 108

The DOI matches its Crossref record.

The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-γ

Zhang, Benyue, Li, Ping, Wang, Exing, Brahmi, Zacharie, Dunn, Kenneth W, Blum, Janice S, Roman, Ann·2003·Virology
DOI 10.1016/s0042-6822(03)00103-x
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0042-6822(03)00103-x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 68

  1. Albanesi, 1998, Interferon-gamma-stimulated human keratinocytes express the genes necessary for the production of peptide-loaded MHC class II molecules, J. Invest Dermatol., 110, 138, 10.1046/j.1523-1747.1998.00098.x · DOI
  2. Amigorena, 1994, Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes, Nature, 369, 113, 10.1038/369113a0 · DOI
  3. Appay, 2002, Characterization of CD4(+) CTLs ex vivo, J. Immunol., 168, 5954, 10.4049/jimmunol.168.11.5954 · DOI
  4. Aubock, 1986, HLA-DR expression on keratinocytes is a common feature of diseased skin, Br. J. Dermatol., 114, 465, 10.1111/j.1365-2133.1986.tb02851.x · DOI
  5. Avva, 1994, In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides, Immunity, 1, 763, 10.1016/S1074-7613(94)80018-9 · DOI
  6. Benaroch, 1995, How MHC class II molecules reach the endocytic pathway, EMBO J., 14, 37, 10.1002/j.1460-2075.1995.tb06973.x · DOI
  7. Beskow, 2001, HLA class II alleles associated with infection by HPV16 in cervical cancer in situ, Int. J. Cancer, 93, 817, 10.1002/ijc.1412 · DOI
  8. Billing, 1976, Isolation and characterization of human B cell alloantigens, J. Immunol., 117, 1589, 10.4049/jimmunol.117.5_Part_1.1589 · DOI
  9. Blum, 1988, Role for intracellular proteases in the processing and transport of class II HLA antigens, Proc. Natl. Acad. Sci. USA, 85, 3975, 10.1073/pnas.85.11.3975 · DOI
  10. Blum, 1991, Proteolytic cleavage of ricin A chain in endosomal vesicles. Evidence for the action of endosomal proteases at both neutral and acidic pH, J. Biol. Chem., 266, 22091, 10.1016/S0021-9258(18)54537-3 · DOI
  11. Bornstein, 1997, Interferon-beta and -gamma, but not tumor necrosis factor-alpha, demonstrate immunoregulatory effects on carcinoma cell lines infected with human papillomavirus, Cancer, 79, 924, 10.1002/(SICI)1097-0142(19970301)79:5<924::AID-CNCR9>3.0.CO;2-B · DOI
  12. Brady, 2000, Multiple mechanisms underlie HLA dysregulation in cervical cancer, Tissue Antigens, 55, 401, 10.1034/j.1399-0039.2000.550502.x · DOI
  13. Chapman, 1998, Endosomal proteolysis and MHC class II function, Curr. Opin. Immunol., 10, 93, 10.1016/S0952-7915(98)80038-1 · DOI
  14. Coleman, 1994, Analysis of HLA-DR expression on keratinocytes in cervical neoplasia, Int. J. Cancer, 56, 314, 10.1002/ijc.2910560303 · DOI
  15. Connor, 1990, Loss of MHC class-I expression in cervical carcinomas, Int. J. Cancer, 46, 1029, 10.1002/ijc.2910460614 · DOI
  16. Conrad, 1993, The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein, J. Virol., 67, 6170, 10.1128/jvi.67.10.6170-6178.1993 · DOI
  17. Cresswell, 1977, Human B cells alloantigens; separation from other membrane molecules by affinity chromatography, Eur. J. Immunol., 7, 636, 10.1002/eji.1830070911 · DOI
  18. Cresswell, 1994, Assembly, transport, and function of MHC class II molecules, Annu. Rev. Immunol., 12, 259, 10.1146/annurev.iy.12.040194.001355 · DOI
  19. Cresswell, 1987, Biosynthesis and processing of class II histocompatibility antigens, Crit Rev. Immunol., 7, 31
  20. Crusius, 1997, Enhancement of EGF- and PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein, Oncogene, 15, 1437, 10.1038/sj.onc.1201312 · DOI · Paper page
  21. Crusius, 1998, The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT, Exp. Cell Res., 241, 76, 10.1006/excr.1998.4024 · DOI · Paper page
  22. Gawkrodger, 1987, Keratinocyte expression of MHC class II antigens in allergic sensitization and challenge reactions and in irritant contact dermatitis, J. Invest. Dermatol., 88, 11, 10.1111/1523-1747.ep12464641 · DOI
  23. Georgopoulos, 2000, Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins, Oncogene, 19, 4930, 10.1038/sj.onc.1203860 · DOI
  24. Glew, 1993, HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection, Eur. J. Cancer, 29A, 1963, 10.1016/0959-8049(93)90453-M · DOI
  25. Glew, 1992, HLA class II antigen expression in human papillomavirus-associated cervical cancer, Cancer Res., 52, 4009
  26. Hwang, 1995, The HPV16 E5 protein, Virology, 211, 227, 10.1006/viro.1995.1395 · DOI
  27. Jenson, 1991, Tissue effects of and host response to human papillomavirus infection, Dermatol. Clin., 9, 203, 10.1016/S0733-8635(18)30410-8 · DOI
  28. Koch, 1982, Structure of Ia antigens, J. Immunol., 128, 1155, 10.4049/jimmunol.128.3.1155 · DOI
  29. Koopman, 1998, HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines, Tissue Antigens, 51, 623, 10.1111/j.1399-0039.1998.tb03005.x · DOI
  30. Krul, 1999, HLA and susceptibility to cervical neoplasia, Hum. Immunol., 60, 337, 10.1016/S0198-8859(98)00127-X · DOI
  31. Lee, 2001, Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells, J. Immunol., 167, 497, 10.4049/jimmunol.167.1.497 · DOI
  32. Leechanachai, 1992, The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus, Oncogene, 7, 19
  33. Loss, 1993, Invariant chain retains MHC class II molecules in the endocytic pathway, J. Immunol., 150, 3187, 10.4049/jimmunol.150.8.3187 · DOI
  34. Maric, 1994, Endosomal aspartic proteinases are required for invariant-chain processing, Proc. Natl. Acad. Sci. USA, 91, 2171, 10.1073/pnas.91.6.2171 · DOI
  35. McFadden, 1994, How DNA viruses perturb functional MHC expression to alter immune recognition, Adv. Cancer Res., 63, 117, 10.1016/S0065-230X(08)60400-5 · DOI
  36. Mommaas, 1995, Distribution of HLA class II molecules in epidermal Langerhans cells in situ, Eur. J. Immunol., 25, 520, 10.1002/eji.1830250232 · DOI
  37. Mota, 1999, The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium, Clin. Exp. Immunol., 116, 33, 10.1046/j.1365-2249.1999.00826.x · DOI
  38. Mutlu, 1991, MHC antigen expression in human oral squamous carcinoma cell lines, J. Pathol., 165, 129, 10.1002/path.1711650208 · DOI
  39. Neefjes, 1992, Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistance alpha beta heterodimers in endosomes, EMBO J., 11, 411, 10.1002/j.1460-2075.1992.tb05069.x · DOI
  40. Nickoloff, 1985, Keratinocyte class II histocompatibility antigen expression, Br. J. Dermatol., 112, 373, 10.1111/j.1365-2133.1985.tb04868.x · DOI
  41. Oelze, 1995, Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line, J. Virol., 69, 4489, 10.1128/jvi.69.7.4489-4494.1995 · DOI
  42. Ostrow, 1987, Epidermodysplasia verruciformis. A case associated with primary lymphatic dysplasia, depressed cell-mediated immunity, and Bowen’s disease containing human papillomavirus 16 DNA, Arch. Dermatol., 123, 1511, 10.1001/archderm.1987.01660350111025 · DOI
  43. Palefsky, 1999, Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women, J. Natl. Cancer Inst., 91, 226, 10.1093/jnci/91.3.226 · DOI
  44. Patil, 2001, Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles, J. Immunol., 167, 7157, 10.4049/jimmunol.167.12.7157 · DOI
  45. Peters, 1991, Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments, Nature, 349, 669, 10.1038/349669a0 · DOI
  46. Pim, 1992, Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor, Oncogene, 7, 27
  47. Radka, 1984, Analysis of monoclonal antibodies reactive with human class II beta chains by two-dimensional electrophoresis and Western blotting, Hum. Immunol., 10, 177, 10.1016/0198-8859(84)90038-7 · DOI
  48. Rheinwald, 1975, Serial cultivation of strains of human epidermal keratinocytes, Cell, 6, 331, 10.1016/S0092-8674(75)80001-8 · DOI
  49. Riese, 1996, Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading, Immunity, 4, 357, 10.1016/S1074-7613(00)80249-6 · DOI
  50. Ritz, 2001, Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma, Int. J. Oncol., 19, 1211
  51. Sadegh-Nasseri, 1991, A role for peptide in determining MHC class II structure, Nature, 353, 167, 10.1038/353167a0 · DOI
  52. Spitkovsky, 2002, The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex, J. Biol. Chem., 277, 25576, 10.1074/jbc.M201884200 · DOI
  53. Stanley, 1994, The host response to lesions induced by human papillomavirus, Ciba Found. Symp., 187, 21
  54. Stebbins, 1995, The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent, J. Exp. Med., 181, 223, 10.1084/jem.181.1.223 · DOI
  55. Stoppler, 1996, The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA, Virology, 223, 251, 10.1006/viro.1996.0475 · DOI · Paper page
  56. Straight, 1995, The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes, J. Virol., 69, 3185, 10.1128/jvi.69.5.3185-3192.1995 · DOI
  57. Thomsen, 1999, The HPV-16 E5 oncogene and bafilomycin A(1) influence cell motility, Biochim. Biophys. Acta, 1452, 285, 10.1016/S0167-4889(99)00132-9 · DOI
  58. Thomsen, 2000, The HPV16 E5 oncogene inhibits endocytic trafficking, Oncogene, 19, 6023, 10.1038/sj.onc.1204010 · DOI
  59. Tindle, 2002, Immune evasion in human papillomavirus-associated cervical cancer, Nat. Rev. Cancer, 2, 59, 10.1038/nrc700 · DOI
  60. Tyring, 2000, Human papillomavirus infections, J. Am. Acad. Dermatol., 43, S18, 10.1067/mjd.2000.107807 · DOI
  61. Vambutas, 2000, Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis, Clin. Diagn. Lab. Immunol., 7, 79, 10.1128/CDLI.7.1.79-85.2000 · DOI
  62. Vambutas, 2001, Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport, Clin. Immunol., 101, 94, 10.1006/clim.2001.5094 · DOI
  63. Vardy, 1990, The cellular immune response to human papillomavirus infection, Int. J. Dermatol., 29, 603, 10.1111/j.1365-4362.1990.tb02579.x · DOI
  64. West, 1994, Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells, Nature, 369, 147, 10.1038/369147a0 · DOI
  65. Wettstein, 1991, Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH, J. Exp. Med., 174, 219, 10.1084/jem.174.1.219 · DOI
  66. Wolf, 1995, How MHC class II molecules acquire peptide cargo, Annu. Rev. Cell Dev. Biol., 11, 267, 10.1146/annurev.cb.11.110195.001411 · DOI
  67. Zhang, 2002, E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis, J. Virol., 76, 220, 10.1128/JVI.76.1.220-231.2002 · DOI · Paper page
  68. zur Hausen, 1991, Human papillomaviruses in the pathogenesis of anogenital cancer, Virology, 184, 9, 10.1016/0042-6822(91)90816-T · DOI

Cited by

Metadata

Authors
Zhang, B., Li, P., Wang, E., Brahmi, Z., Dunn, K. W., Blum, J. S., & Roman, A.
Venue
Virology
Publisher
Elsevier BV
Published
2003-05
Volume
310
Issue
1
Pages
100-108
ISSN
0042-6822
DOI
10.1016/s0042-6822(03)00103-x
Cited by
108
References
0
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review